Sjogren's Syndrome Clinical Trials

227 clinical trials for Sjogren's Syndrome across international registries, including 38 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease — RECRUITING · PHASE1
• Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders — RECRUITING · NA
• The Pathogenesis and Natural History of Sjogren's Disease — RECRUITING
• Characterization of Diseases With Salivary Gland Involvement — RECRUITING
• A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases — RECRUITING · PHASE1
• Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease — RECRUITING · PHASE2
• MTS109 in Patients With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome — RECRUITING · NA
• A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE — RECRUITING · PHASE2
• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — RECRUITING · PHASE3
• Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Rheumatology Patient Registry and Biorepository — RECRUITING
• Maternal Autoimmune Disease Research Alliance (MADRA) Registry — RECRUITING
• Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases — RECRUITING
• Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis — RECRUITING
• Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT — RECRUITING · PHASE1
• A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE 3 PROTOCOL TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB IN ADULTS WITH MODERATE TO SEVERE SJÖGREN'S DISEASE (SJD) — RECRUITING
• Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) — RECRUITING · PHASE2
• Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases — RECRUITING
• Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments — RECRUITING
• Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome — RECRUITING
• Rheumatology Diet Study — RECRUITING
• Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases — RECRUITING · NA
• Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) — RECRUITING · PHASE1
• An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease — RECRUITING · NA
• Ultra-High Frequency Ultrasonography in Sjögren's Syndrome — RECRUITING · NA
• Belimumab After Rituximab in Resistant Primary Juvenile SS — RECRUITING · PHASE4
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAZODALIBEP IN PARTICIPANTS WITH SJOGREN'S SYNDROME WITH MODERATE TO SEVERE SYMPTON STATE — RECRUITING · PHASE3
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAZODALIBEP IN PARTICIPANTS WITH SJÖGREN¿S SYNDROME WITH MODERATE-TO-SEVERE SYSTEMIC DISEASE ACTIVITY — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DEUCRAVACITINIB IN ADULTS WITH ACTIVE SJÖGRENS SYNDROME (POETYK SJS-1) — RECRUITING · PHASE3
• Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease — RECRUITING · PHASE1
• A RANDOMIZED, DOUBLE-BLIND 2-ARM NEPTUNUS EXTENSION STUDY TO ACCESS THE LONG-TERM SAFETY AND EFFICACY OF IANALUMAB IN PATIENTS WITH SJOGREN'S SYNDROME — RECRUITING
• A 48-WEEK, 6-ARM, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL TO ASSESS THE SAFETY AND EFFICACY OF MULTIPLE CFZ533 DOSES ADMINISTERED SUBCUTANEOUSLY IN TWO DISTINCT POPLUATIONS OF PATIENTS WITH SJOGREN'S SYNDROME (TWINSS) — RECRUITING
• Meir Medical Center Rheumatologic Biobank — RECRUITING
• Sjogren's Mini-Pill Oral and Gut Microbiome Study — NOT_YET_RECRUITING · NA
• Comprehensive Evaluation of Clinical and Biopsychosocial Characteristics in Primary Sjögren's Disease — COMPLETED
• Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism — COMPLETED
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2A/B STUDY ASSESSING THE EFFICACY, SAFETY AND TOLERABILITY OF DDY391 IN PARTICIPANTS WITH SJÖGREN'S DISEASE — NOT_YET_RECRUITING · PHASE2
• A Study of BEN301 Injection in theTreatment of Autoimmune Diseases — SUSPENDED · PHASE1
• A 52 WEEK, 2 ARM RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL ASSESSING THE EFFICACY AND SAFETY OF IANALUMAB IN PATIENTS WITH SJOGREN'S DISEASE WITH A GLANDULAR PREDOMINANT PHENOTYPE-HIGH SYMPTOM BURDEN AND LOW SYSTEMIC DISEASE ACTIVITY (THALASSA) — NOT_YET_RECRUITING
• Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome — COMPLETED · NA
• A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjögren’s syndrome (NEPTUNUS-2) — TERMINATED · PHASE3
• A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome — TERMINATED · PHASE2
• Wheat-free Diet in the Treatment of Sjogren's Syndrome — COMPLETED · NA
• Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases — ACTIVE_NOT_RECRUITING · PHASE4
• Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome — ACTIVE_NOT_RECRUITING · NA

Refine this search